Johannson Kerri, Collard Harold R
Division of Respirology, Department of Medicine, University of Calgary, Calgary AB ; Division of Pulmonary, Critical Care Medicine, Sleep and Allergy, Department of Medicine, University of California, San Francisco, CA.
Division of Pulmonary, Critical Care Medicine, Sleep and Allergy, Department of Medicine, University of California, San Francisco, CA.
Curr Respir Care Rep. 2013 Dec;2(4). doi: 10.1007/s13665-013-0065-x.
Acute exacerbation of idiopathic pulmonary fibrosis (IPF) occurs in roughly 10% of patients annually, and is a leading cause of morbidity and mortality in this disease. While currently defined as idiopathic acute worsenings, acute exacerbations of IPF may in fact have a variety of causes, in particular infection and aspiration. Central to the pathobiology of clinically meaningful events is a diffuse injury to the IPF lung manifest histopathologically as diffuse alveolar damage, and biologically as accelerated alveolar epithelial cell injury or repair. Based on these recent observations, we propose a new paradigm for acute exacerbation of IPF that removes the idiopathic requirement and focuses on the pathophysiological mechanism involved.
特发性肺纤维化(IPF)急性加重每年约发生在10%的患者中,是该病发病和死亡的主要原因。虽然目前将其定义为特发性急性恶化,但IPF急性加重实际上可能有多种原因,尤其是感染和误吸。具有临床意义事件的病理生物学核心是IPF肺的弥漫性损伤,在组织病理学上表现为弥漫性肺泡损伤,在生物学上表现为肺泡上皮细胞损伤或修复加速。基于这些最新观察结果,我们提出了一种IPF急性加重的新范式,该范式去除了特发性这一要求,并专注于所涉及的病理生理机制。